Presentation THT 2023

FDA Guidance on Meaningful Representation in Clinical Trials

Presenter: Bram D. Zuckerman

March 20, 2023

REGISTER for free or LOG IN to view this content

FDA Guidance on Meaningful Representation in Clinical Trials

Heart Failure

THT 2023

Policy & Practice

Up Next

Presentation THT 2023

SGLT2 Inhibitors Have a Unique Mechanism That Accounts for Their Comprehensive Benefits

Presenter: Milton Packer

March 20, 2023

More slides +

Presentation THT 2023

IASDs: What We Know and What We Don't Know

Presenter: Sanjiv J. Shah

March 20, 2023

Presentation THT 2023

Heart Team Decision: Revascularization vs Medical Management

Presenter: Anuradha Lala-Trindade

March 20, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.